Cargando…
Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies
This report summarizes key issues contributing to the cost of preparing human pluripotent stem cell lines for use in cell therapy manufacturing based on discussion between stem cell banking experts from ten countries at a workshop session on ‘cost of goods’ for human pluripotent stem cell banking or...
Autores principales: | Kim, Jung-Hyun, Kawase, Eihachiro, Bharti, Kapil, Karnieli, Ohad, Arakawa, Yuji, Stacey, Glyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522845/ https://www.ncbi.nlm.nih.gov/pubmed/36175440 http://dx.doi.org/10.1038/s41536-022-00242-7 |
Ejemplares similares
-
A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017
por: Kim, Jung‐Hyun, et al.
Publicado: (2019) -
Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent
por: Bodbin, Sara E., et al.
Publicado: (2020) -
hPSC-derived organoids: models of human development and disease
por: Frum, Tristan, et al.
Publicado: (2020) -
hPSC-derived lung organoids: Potential opportunities and challenges
por: Du, Xiaoli, et al.
Publicado: (2023) -
Correction to: hPSC-derived organoids: models of human development and disease
por: Frum, Tristan, et al.
Publicado: (2020)